Web2. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE RETHYMIC® is indicated for immune reconstitution in pediatric patients with congenital athymia.. Limitations of Use • RETHYMIC is not ... WebOct 1, 2024 · The treatment in question, potentially to be known as Rethymic (allogeneic processed thymus tissue-agdc), would be the first for the ultra-rare condition in which chil ...
HCP – About Us RETHYMIC® (allogeneic processed thymus …
WebJan 4, 2024 · recipient BSA. Rethymic slices are variable in size and shape and the dose of manufactured Rethymic will be calculated at the facility to correspond to the patient’s calculated dose. The recommended dose range is 5,000 to 22,000 mm2 of Rethymic/m2 recipient BSA – up to 42 cultured Rethymic slices will be provided for each patient. WebOct 11, 2024 · Rethymic (allogeneic processed thymus tissue -agdc) for children with congenital athymia. Congenital athymia is an ultra-rare disease in children born without a thymus. It results in life-threatening immune dysregulation. A T-cell deficiency initially identifies the disease in newborn screening for severe combined immune deficiency … horrible histories i sat on the bus
FDA Approves Rethymic for Pediatric Congenital Athymia
WebOct 14, 2024 · According to a company press release, Rethymic is the first and only FDA-approved treatment for immune reconstitution of congenital athymia. Enzyvant has obtained a priority review voucher for Rethymic under the Rare Pediatric Disease Program. Congenital athymia is a rare condition, with approximately 17–24 new cases occurring each year. WebRETHYMIC is administered by a surgical procedure. The recommended dose range is 5,000 to 22,000 mm 2 of RETHYMIC/m 2 recipient body surface area (BSA). (2) … WebPlease see additional Important Safety Information on pages 14 & 15, and the enclosed full Prescribing Information. Survival Data3,5 (cont’d) For patients who were alive at 1 year … lower back muscle spasms icd 10